Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 4
2005 2
2007 4
2008 2
2009 4
2010 2
2012 7
2013 3
2014 1
2016 2
2017 5
2018 1
2019 3
2020 3
2021 4
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug.
de Brito E Cunha D, Frederico ABT, Azamor T, Melgaço JG, da Costa Neves PC, Bom APDA, Tilli TM, Missailidis S. de Brito E Cunha D, et al. Among authors: missailidis s. Pharmaceuticals (Basel). 2022 May 5;15(5):575. doi: 10.3390/ph15050575. Pharmaceuticals (Basel). 2022. PMID: 35631401 Free PMC article. Review.
Nanoparticle conjugated with aptamer anti-MUC1/Y for inflammatory arthritis.
Corrêa LB, Pinto SR, Alencar LMR, Missailidis S, Rosas EC, Henriques MDGMO, Santos-Oliveira R. Corrêa LB, et al. Among authors: missailidis s. Colloids Surf B Biointerfaces. 2022 Mar;211:112280. doi: 10.1016/j.colsurfb.2021.112280. Epub 2021 Dec 9. Colloids Surf B Biointerfaces. 2022. PMID: 34902784
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs.
Melgaço JG, Brito E Cunha D, Azamor T, da Silva AMV, Tubarão LN, Gonçalves RB, Monteiro RQ, Missailidis S, da Costa Neves PC, Ano Bom APD. Melgaço JG, et al. Among authors: missailidis s. J Immunol Res. 2020 Dec 19;2020:8827670. doi: 10.1155/2020/8827670. eCollection 2020. J Immunol Res. 2020. PMID: 33426096 Free PMC article. Review.
Aptamer-based nanoparticles for cancer targeting.
Sá LT, Simmons S, Missailidis S, da Silva MI, Santos-Oliveira R. Sá LT, et al. Among authors: missailidis s. J Drug Target. 2013 May;21(5):427-34. doi: 10.3109/1061186X.2012.761222. Epub 2013 Jan 25. J Drug Target. 2013. PMID: 23350808
Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.
Melgaço JG, Azamor T, Silva AMV, Linhares JHR, Dos Santos TP, Mendes YS, de Lima SMB, Fernandes CB, da Silva J, de Souza AF, Tubarão LN, Brito E Cunha D, Pereira TBS, Menezes CEL, Miranda MD, Matos AR, Caetano BC, Martins JSCC, Calvo TL, Rodrigues NF, Sacramento CQ, Siqueira MM, Moraes MO, Missailidis S, Neves PCC, Ano Bom APD. Melgaço JG, et al. Among authors: missailidis s. Cells. 2021 Aug 26;10(9):2206. doi: 10.3390/cells10092206. Cells. 2021. PMID: 34571855 Free PMC article.
48 results